drugset / Trial / NCT04189276
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
A multi-center, randomized, open-label, group controlled study to evaluate the safety and efficacy of T101 combined with nucleoside (acid) analogues in chronic hepatitis B patients.
Timeline
- Start
- 2019-12-10
- Primary completion
- 2021-06-30
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Entecavir | Small molecule | — | — |
| Comparator | Peginterferon alfa-2b | Protein / enzyme biologic | — | — |
| Comparator | TELIMOMAB ARITOX | Vaccine | — | Other |
| Comparator | Tenofovir | Small molecule | — | — |